Live Breaking News & Updates on Searchlight Support

Stay updated with breaking news from Searchlight support. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mitsubishi Tanabe Pharma America Celebrates Five Years of Dedication to the ALS Community in the U.S.


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Mitsubishi Tanabe Pharma America Celebrates Five Years of Dedication to the ALS Community in the U.S.
February 8, 2021 GMT
MTPA Logo (PRNewsfoto/Mitsubishi Tanabe Pharma Americ)
JERSEY CITY, N.J., Feb. 8, 2021 /PRNewswire/ Mitsubishi Tanabe Pharma America, Inc. (MTPA) today celebrated its five-year anniversary of being established in the United States in 2016. MTPA has followed an unwavering patient-first philosophy focused on advancing innovative treatments for people facing serious and life-threatening diseases, including amyotrophic lateral sclerosis (ALS).
“Having personally been a part of the MTPA journey from the beginning, I am humbled by what we have achieved as one team, with one mission: helping patients,” said Atsushi Fujimoto, President, MTPA. “We have accomplished many things in the first five years working together to serve the ALS community, and we ....

United States , Ch Ungch Ong Namdo , South Korea , Debbie Etchison , Tanabe Pharma , Atsushi Fujimoto , Donalds Wood , Muscular Dystrophy Association , Mitsubishi Tanabe Pharma America Inc , Assistance Program , Mitsubishi Tanabe Pharma Corporation , Prnewswire Mitsubishi Tanabe Pharma America Inc , Drug Administration , Mitsubishi Tanabe Pharma Development America Inc , Overview Of Mitsubishi Tanabe Pharma Corporation , Mitsubishi Tanabe Pharma Holdings America Inc , Tanabe Pharma America , Mitsubishi Tanabe Pharma Canada , Muscular Dystrophy , Searchlight Support , Out Of Pocket Assistance , Mitsubishi Tanabe Pharma Development America , Mitsubishi Tanabe Pharma America , Prescribing Information , Patient Information , Aquestive Therapeutics ,

Mitsubishi Tanabe Pharma America Announces Enhancements to Out-Of-Pocket Assistance Program for Eligible ALS Patients Treated with RADICAVA® (edaravone)


Share this article
Share this article
JERSEY CITY, N.J., Jan. 14, 2021 /PRNewswire/  Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced upgrades to its out-of-pocket assistance program that aim to provide enhanced support for eligible patients with amyotrophic lateral sclerosis (ALS) treated with RADICAVA
® (edaravone) through more efficient communication and exchange of information, including a new hybrid card that can be used to help access appropriate pharmacy and medical co-pay assistance.  
Our modified all-in-one out-of-pocket assistance program was designed with our patients in mind, to continue to support appropriate, affordable access to treatment with RADICAVA, for eligible patients, said Kevin O Brien, Vice President of Market Access, MTPA. We changed the program processes for handling pharmacy and medical benefit claims to allow patients to use one card, on-the-spot. In addition, we have modified logistical procedures related to c ....

United States , Rhode Island , Ch Ungch Ong Namdo , South Korea , Debbie Etchison , Tanabe Pharma , Kevin Obrien , Mitsubishi Tanabe Pharma America Inc , Assistance Program , Department Of Defense , Mitsubishi Tanabe Pharma Corporation , Drug Administration , Veterans Administration , Overview Of Mitsubishi Tanabe Pharma Corporation , Mitsubishi Tanabe Pharma Holdings America Inc , Mitsubishi Tanabe Pharma America , Kevino Brien , Vice President , Market Access , Out Of Pocket Assistance Program , Searchlight Support , Prescribing Information , Patient Information , Jersey City , Mitsubishi Tanabe Pharma Holdings America , Mitsubishi Tanabe Pharma ,